eTable 6. Sensitivity analysis of the first primary endpoint DAS28—full model in the intention-to-treat population.
Group comparison team-based − standard | ||||
Model coefficient*1 | 95% confidence interval | p value | p value non-inferiority | |
(Intercept) | 1.56 | [1.21; 1.91] | < 0.001 | |
Baseline DAS28 | −0.41 | [−0.48; −0.34] | < 0.001 | |
Male sex | −0.33 | [−0.54; −0.13] | 0.002 | |
New form of care | −0.18 | [−0.35; −0.02] | 0.032 *2 | < 0.001 |
Psoriatic arthritis | −0.00 | [−0.23; 0.22] | 0.972 |
*1 estimated using a linear mixed model with the variables listed and with a random center effect
*2 p value for superiority DAS28, Disease Activity Score with 28 joints